Clinical Trial Update: A Study to Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Disease

View source ↗

Summary

Pfizer is conducting a study to evaluate ABRYSVO for preventing severe respiratory syncytial virus infection in older adults, with the trial currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• ABRYSVO

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Viruses | Status: ACTIVE_NOT_RECRUITING